Fosun biotech unit Henlius has no plans for Shanghai tech board listing and is focused on Hong Kong IPO

Shanghai Henlius Biotech, a spin-off of Hong Kong and mainland China-listed Fosun Pharmaceutical, said it had no immediate plans of listing on Shanghai’s upcoming Technology Innovation Board, as it …
( read original story …)

---